ArticleQuantitative imaging in medicine and surgery2025
TransDualSegNet: transformer dual segment network for retinal vasculature segmentation in OCT.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early diagnosis and treatment of eye diseases is crucial for preserving vision, and optical coherence tomography (OCT) has become a common non-invasive technique for eye examinations. In particular, retinal vessel segmentation in OCT images is a critical task that provides detailed information such as vessel diameter and wall thickness, serving as important diagnostic aids for ophthalmologists. This study aimed to develop an efficient and accurate retinal vessel segmentation method in OCT images to improve the diagnosis and treatment of eye diseases. Methods: Transformer Dual Segment Network (TransDualSegNet) involves several key steps: firstly, the OCT images are preprocessed through denoising and brightness adjustment to enhance the performance of subsequent segmentation algorithms. Secondly, we introduce an encoder-decoder model with the Pyramid Vision Transformer as the encoding layer, which automatically learns the feature representation of retinal vessels to improve segmentation accuracy and robustness. The decoder utilizes a dual-branch convolutional network that incorporates and emphasizes the edge information of retinal vessel OCT images as complementary information for vessel segmentation. Finally, a feature fusion module (FFM) is applied to fuse the global features and edge features, which are fed into the edge extraction module to generate the final edge probability map and obtain the segmentation results. Results: Experimental results on the OCT vessel segmentation dataset showed that the proposed model outperformed U-Net, Attention U-Net, and Trans U-Net, with accuracy (ACC) 91.13%±0.11%, sensitivity (SE) 90.02%±0.38%, Jaccard similarity (JS) 93.92%±0.13%, and Dice coefficient (DICE) 90.26%±0.25% all higher than comparisons. The model has 9.82 M parameters, falling between the comparison models, and a forward inference time of 20.3 ms, faster than Attention U-Net and Trans U-Net, balancing high accuracy and efficiency. Ablation experiments showed that it outperformed all sub-models in metrics such as ACC, SE, specificity (SP), Intersection over Union (IOU), and area under the curve (AUC), with IOU reaching 93.92%±0.13% and AUC 93.04%±0.34%, verifying the synergistic effectiveness of each component. Conclusions: TransDualSegNet, with its innovative architecture and outstanding segmentation performance, offers a novel solution for retinal vessel segmentation. Although there is room for optimization, its technical advantages and clinical potential provide valuable insights for advancing medical image processing and ophthalmic diagnostic technologies. Precise retinal vessel segmentation aids in diagnosing diabetic retinopathy and hypertensive retinopathy, facilitating automatic measurement of parameters such as vessel diameter and wall thickness to offer more accurate treatment recommendations for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.